Drugs / COL-101
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00495313 | Mar → Dec 2007 | rosacea | CollaGenex Pharmaceuticals | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00560703 Comparator | Nov 2007 → May 2009 | blepharitis, dry eye syndrome | Galderma R&D | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COL-101 | “COL-101, QD plus metronidazole” NCT00495313 ↗ |
| Known as | doxycycline, USP | “COL-101 (doxycycline, USP) capsules” NCT00560703 ↗ |